103395898
voted
Hey, mooers!
Recent weeks have witnessed notable market fluctuations due to a confluence of factors, including corporate earnings releases, economic indicators, and political events. Amidst this tumultuous backdrop, August stands out as a month teeming with key topics and decisions that could shape the trajectory of global markets. Investors are observing the Federal Reserve's annual Jackson Hole symposium with interest, staying informed on politic...
Recent weeks have witnessed notable market fluctuations due to a confluence of factors, including corporate earnings releases, economic indicators, and political events. Amidst this tumultuous backdrop, August stands out as a month teeming with key topics and decisions that could shape the trajectory of global markets. Investors are observing the Federal Reserve's annual Jackson Hole symposium with interest, staying informed on politic...
53
12
10
103395898
voted
Good morning, traders. Happy Thursday, the market is trying to climb up after falling back. The Nasdaq and tech stocks were still in correction territory from their heights in the lush days of July. My name is Kevin Travers, here are moovin' stonks.
Eli Lilly $Eli Lilly and Co (LLY.US)$ posted a Q2 earnings beat, boosted by demand for the company's Mounjaro diabetes treatment and weight-loss drug Zepbound. The stock climbed 8%, and ...
Eli Lilly $Eli Lilly and Co (LLY.US)$ posted a Q2 earnings beat, boosted by demand for the company's Mounjaro diabetes treatment and weight-loss drug Zepbound. The stock climbed 8%, and ...
22
3